Review
Accepted on 10 Apr 2025
Methyltransferase-like 3 is a Target for the Diagnose and Therapy of Clear Cell Renal Carcinoma
in Renal Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2025.1534655
Type at least 3 characters
628 articles
Original Research
Published on 09 Apr 2025
TRPC3 contributes to cyclophosphamide-induced cystitis progression by enhancing bladder fibrosis through activation of the TGF-β/smad pathway
in Renal Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2025.1565156
- 180 views
Original Research
Published on 08 Apr 2025
Vaccinium myrtillus L. ameliorates diabetic nephropathy via modulating metabolites and gut microbiota in rats
in Renal Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2025.1541947
- 192 views
Review
Published on 08 Apr 2025
Overview of pharmacodynamical research of traditional Chinese medicine on hyperuricemic nephropathy: from the perspective of dual-regulatory effect on the intestines and kidneys
in Renal Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2025.1517047
- 148 views
Review
Accepted on 07 Apr 2025
An update on renal tubular injury as related to glycolipid metabolism in diabetic kidney disease
in Renal Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2025.1559026
Mini Review
Accepted on 04 Apr 2025
Quantification of Endogenous and Therapeutic IgG Crossing the Kidney Barrier from Bloodstream to Urine
in Renal Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2025.1572739
Systematic Review
Accepted on 04 Apr 2025
Safety and efficacy of intravesical instillation of botulinum toxin-A in the treatment of interstitial cystitis/bladder pain syndrome and overactive bladder: a systematic review and meta-analysis
in Renal Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2025.1586845
- 107 views
Original Research
Published on 04 Apr 2025
Eculizumab is efficacious and safe in pediatric patients with various forms of hemolytic uremic syndrome: a retrospective clinical experience of a tertiary center
in Renal Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2025.1535407
- 265 views
Original Research
Published on 04 Apr 2025
Landscape analysis of m6A modification regulators reveals LRPPRC as a key modulator in tubule cells for DKD: a multi-omics study
in Renal Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2025.1506896
- 126 views
Original Research
Published on 04 Apr 2025
Endoplasmic reticulum stress aggravates ferroptosis via PERK/ATF4/HSPA5 pathway in UUO-induced renal fibrosis
in Renal Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2025.1545972
- 126 views
Original Research
Accepted on 02 Apr 2025
5-Methoxytryptophan Ameliorates Renal Ischemia/Reperfusion Injury by Alleviating Endoplasmic Reticulum Stress-mediated Apoptosis through the Nrf2/HO-1 Pathway
in Renal Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2025.1506482
Review
Published on 01 Apr 2025
The molecular determinants regulating redox signaling in diabetic endothelial cells
in Renal Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2025.1563047
- 305 views
Review
Accepted on 31 Mar 2025
Gut Microbiome Dynamics of Patients on Dialysis: Implications for Complications and Treatment
in Renal Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2025.1470232
Review
Accepted on 28 Mar 2025
Natural products in traditional Chinese medicine for renal fibrosis: A comprehensive review
in Renal Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2025.1560567
Original Research
Published on 27 Mar 2025
Drug-induced kidney stones: a real-world pharmacovigilance study using the FDA adverse event reporting system database
in Renal Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2025.1511115
- 317 views
Systematic Review
Published on 27 Mar 2025
Clinical efficacy and safety of sodium-glucose cotransporter protein-2 (SGLT-2) inhibitor, glucagon-like peptide-1 (GLP-1) receptor agonist, and Finerenone in type 2 diabetes mellitus with non-dialysis chronic kidney disease: a network meta-analysis of randomized clinical trials
in Renal Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2025.1517272
- 541 views